May 8, 2018 · For men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)-based screening for prostate cancer should be an individual one.

Feb 11, 2025 · In 2018, the US Preventive Services Task Force (USPSTF) made the following recommendations about prostate cancer screening: Men who are 55 to 69 years old should …

According to the U.S. Preventive Services Task Force (USPSTF), for men aged 55 to 69 years, the decision should be individually made to undergo periodic prostate-specific antigen (PSA) …

Conclusions and Recommendation For men aged 55 to 69 years, the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one and should include …

Mar 8, 2024 · The USPSTF, alternatively, recommends these prostate cancer screening guidelines: Men ages 55 to 69: Men should discuss a prostate-specific antigen (PSA) …

Oct 15, 2018 · For men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)–based screening for prostate cancer should be an individual one.

Understanding how USPSTF guidelines shape screening practices is essential for informed decision-making and public health outcomes. Screening's role in early detection and treatment …

May 8, 2018 · How each man weighs specific benefits and harms will determine whether the overall net benefit is small. The USPSTF concludes with moderate certainty that the potential …

The USPSTF also commissioned a review of existing decision analysis models and the overdiagnosis rate of PSA-based screening. The reviews also examined the benefits and …

The U.S. Preventive Services Task Force (USPSTF) recommends that men ages 55 to 69 years discuss the possible benefits and harms of prostate-specific antigen (PSA) screening with their …